BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12183561)

  • 21. The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi.
    Calderón J; Maganto-Garcia E; Punzón C; Carrión J; Terhorst C; Fresno M
    PLoS Pathog; 2012; 8(7):e1002799. PubMed ID: 22807679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.
    Barroso A; Gualdrón-López M; Esper L; Brant F; Araújo RR; Carneiro MB; Ávila TV; Souza DG; Vieira LQ; Rachid MA; Tanowitz HB; Teixeira MM; Machado FS
    Infect Immun; 2016 Oct; 84(10):3071-82. PubMed ID: 27481250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Trypanosoma cruzi infection on nitric oxide synthase and arginase expression and activity in young and elderly mice.
    Felizardo AA; Caldas IS; Mendonça AAS; Gonçalves RV; Tana FL; Almeida LA; Novaes RD
    Free Radic Biol Med; 2018 Dec; 129():227-236. PubMed ID: 30248443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
    Hernández M; Wicz S; Corral RS
    Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
    Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
    Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.
    Silva MC; Davoli-Ferreira M; Medina TS; Sesti-Costa R; Silva GK; Lopes CD; Cardozo LE; Gava FN; Lyroni K; Dias FC; Frade AF; Baron M; Nakaya HI; Figueiredo F; Alves-Filho JC; Cunha FQ; Tsatsanis C; Chevillard C; Cunha-Neto E; Hirsch E; Silva JS; Cunha TM
    Nat Commun; 2018 Apr; 9(1):1513. PubMed ID: 29666415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-dimensional multi-agent-based model for the evolution of Chagas' disease.
    Galvão V; Miranda JG
    Biosystems; 2010 Jun; 100(3):225-30. PubMed ID: 20347006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-10 participates in the expansion and functional activation of CD8
    Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
    J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma cruzi: biotherapy made from trypomastigote modulates the inflammatory response.
    Sandri P; Aleixo DL; Sanchez Falkowski GJ; Nascimento Júnior AD; Gomes ML; Hernandes L; Machado de Oliveira Dalalio M; Moreira NM; Toledo MJ; Gabriel M; de Araújo SM
    Homeopathy; 2015 Jan; 104(1):48-56. PubMed ID: 25576271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3: A Friend but Not a Foe during
    da Silva AA; Teixeira TL; Teixeira SC; Machado FC; Dos Santos MA; Tomiosso TC; Tavares PCB; Brígido RTES; Martins FA; Silva NSL; Rodrigues CC; Roque-Barreira MC; Mortara RA; Lopes DS; Ávila VMR; da Silva CV
    Front Cell Infect Microbiol; 2017; 7():463. PubMed ID: 29164071
    [No Abstract]   [Full Text] [Related]  

  • 32. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice.
    Rodriguez HO; Guerrero NA; Fortes A; Santi-Rocca J; Gironès N; Fresno M
    Acta Trop; 2014 Nov; 139():57-66. PubMed ID: 25017312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
    Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Posaconazole in an in vitro model of cardiac fibrosis induced by Trypanosoma cruzi.
    Nisimura LM; Ferrão PM; Nogueira ADR; Waghabi MC; Meuser-Batista M; Moreira OC; Urbina JA; Garzoni LR
    Mol Biochem Parasitol; 2020 Jul; 238():111283. PubMed ID: 32564978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
    Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
    Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression.
    Taniwaki NN; Gonçalves VM; Romero JK; da Silva CV; da Silva S; Mortara RA
    Parasitol Res; 2011 Aug; 109(2):431-40. PubMed ID: 21331788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.
    de Oliveira FL; Araújo-Jorge TC; de Souza EM; de Oliveira GM; Degrave WM; Feige JJ; Bailly S; Waghabi MC
    PLoS Negl Trop Dis; 2012; 6(6):e1696. PubMed ID: 22720109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.